81 FR 38709 - Proposed Information Collection Activity: Comment Request
DEPARTMENT OF HEALTH AND HUMAN SERICES
Administration for Children and Families Federal Register Volume 81, Issue 114 (June 14, 2016)
Administration for Children and Families
Federal Register Volume 81, Issue 114 (June 14, 2016)
| Page Range | 38709-38710 | |
| FR Document | 2016-13999 |
[Federal Register Volume 81, Number 114 (Tuesday, June 14, 2016)] [Notices] [Pages 38709-38710] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-13999] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERICES Administration for Children and Families Proposed Information Collection Activity: Comment Request Proposed Projects Title: National Study of Title IV-E Child Welfare Waiver Demonstrations. OMB No.: New Collection. Description: The National Study of the Title IV-E Child Welfare Waiver Demonstrations is sponsored by the Children's Bureau, Administration for Children and Families of the U.S. Department of Health and Human Services and involves the conduct of a cross-site study of jurisdictions (referred to as waiver jurisdictions) approved to operate demonstrations authorized by section 1130 of the Social Security Act, as amended by the Child and Family Services Improvement and Innovation Act, Public Law 112-34. The demonstrations involve waivers of certain provisions of the foster care program authorized by title IV-E of the Social Security Act. Child welfare agencies in waiver jurisdictions are operating demonstrations to implement a variety of programs and interventions that serve children and families in an effort to improve their safety, permanency, and well-being. Each waiver jurisdiction is required to conduct a third-party evaluation of its demonstration. The National Study will examine the extent to which safety, permanency, and well-being outcomes have improved for children and families; the characteristics of waiver jurisdictions where improvements in outcomes have occurred; expenditure patterns and the types of activities for which waiver jurisdictions have increased funding; and the extent to which waiver jurisdictions have experienced practice and systems-level changes. The National Study uses a mixed- method approach to examine 25 waiver jurisdictions (including 23 states, the District of Columbia and one tribal government) with Terms and Conditions approved in Federal Fiscal years 2012, 2013, and 2014. Proposed data collection methods are two topically-focused telephone surveys: (a) A telephone survey of waiver jurisdiction representatives and evaluators who are focused on measuring well-being, and (b) a second telephone survey of waiver jurisdiction representatives and evaluators that is focused on understanding practice and systems-level changes within child welfare service systems. Also proposed is a Web- based survey of waiver jurisdiction representatives and evaluators that will look more broadly at the implementation of waiver demonstrations and corresponding changes in child welfare policy, practice, and financing. Data collected through these instruments will be used by the Children's Bureau to gain an understanding of the jurisdictions' collective experience with implementing their demonstrations. Respondents: The respondents to the Web-based survey will be a purposive sample of an estimated 250 waiver jurisdiction representatives and evaluators drawn from the 25 waiver jurisdictions with waiver demonstration [[Page 38710]] projects (Arkansas, Arizona, Colorado, Hawaii, Illinois, Kentucky, Maine, Maryland, Massachusetts, Michigan, Nebraska, Nevada, New York, Oklahoma, Oregon, Pennsylvania, Port Gamble S'Klallam Tribe, Rhode Island, Tennessee, Texas, Utah, Washington, Washington DC, West Virginia, Wisconsin). The Web-based survey will be administered once during the National Study. The respondents to the Well-Being telephone survey will be a purposive sample of 60 respondents identified from up to 12 waiver jurisdictions who are involved with the assessment of child and family well-being in their waiver jurisdictions. The Well- Being telephone survey will be administered once during the National Study. The respondents to the Practice and Systems-Level Change telephone survey will be a purposive sample of 60 respondents identified from up to 12 waiver jurisdictions who are knowledgeable about practice, policy, and organizational changes in their respective waiver jurisdictions. The Practice and Systems-Level Change telephone survey will be administered once during the National Study. Annual Burden Estimates ---------------------------------------------------------------------------------------------------------------- Number of Average Instrument Number of responses per burden hours Total burden respondents respondent per response hours ---------------------------------------------------------------------------------------------------------------- Web-Based Survey................................ 250 1 0.33 82.5 Telephone Survey: Well-Being.................... 60 1 1 60 Telephone Survey: Practice and Systems-Level 60 1 1 60 Change......................................... --------------------------------------------------------------- Estimated Total Annual Burden Hours......... .............. .............. .............. 202.5 ---------------------------------------------------------------------------------------------------------------- In compliance with the requirements of section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collected described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 330 C St. SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email address: [email protected]. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information (c) the quality, utility and clarity of the information to be collected, and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Robert Sargis, Reports Clearance Officer. [FR Doc. 2016-13999 Filed 6-13-16; 8:45 am] BILLING CODE 4184-01-P
![Federal Register / Vol. 81, No. 114 / Tuesday, June 14, 2016 / Notices 38709
interview will be specific to the anticipates conducting I-Catalyst with value and need and their top barriers
proposed solution and context. For three cohorts of teams over the next two and pain points.
example, teams may interview years. With each I-Catalyst cohort teams CDC expects that teams participating
government employees if the solution is will interview their customers/ in the I-Catalyst will be empowered to
intended to improve how government stakeholders for an average of 30 implement innovative strategies and
employees do their work. On the other minutes. Each team will interview solutions that create value for a set of
hand, teams may interview individuals approximately 50 respondents. With 8– beneficiaries. The ultimate goal of the I-
who work industry and businesses if the 10 teams participating in each of the Catalyst program is to give CDC staff
teams determines that they are the three I-Catalyst training cohorts, skills to successfully transfer knowledge
intended beneficiaries. approximately 1,500 respondents will into value-based solutions that benefit
Using a generic information collection be interviewed. Of these, approximately society and broaden the agency’s
plan, this data collection covers 40% of individuals will be internal impact.
qualitative information to be obtained Participation in the I-Catalyst
CDC/ATSDR staff and 60% will be
through on-site, unstructured interviews interviews is completely voluntary. A
external partners, stakeholders, or
with individuals who represent the three-year approval is requested. There
customers or stakeholders CDC teams customers. Data to be collected includes is no cost to respondents other than
are attempting to serve or benefit. CDC information regarding what they most their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average Total
Number of responses burden per
Type of respondents Form name burden
respondents per response (in hrs.)
respondent (in hrs.)
Cohort 1:
External Partners, Stakeholders, or Cus- Forms will not be used 500 1 1 500
tomers.
Cohort 2:
External Partners, Stakeholders, or Cus- Forms will not be used 500 1 1 500
tomers.
Cohort 3:
External Partners, Stakeholders, or Cus- Forms will not be used 500 1 1 500
tomers.
Total ....................................................... ....................................... ........................ ........................ ........................ 1,500
Leroy A. Richardson, section 1130 of the Social Security Act, Columbia and one tribal government)
Chief, Information Collection Review Office, as amended by the Child and Family with Terms and Conditions approved in
Office of Scientific Integrity, Office of the Services Improvement and Innovation Federal Fiscal years 2012, 2013, and
Associate Director for Science, Office of the Act, Public Law 112–34. The 2014. Proposed data collection methods
Director, Centers for Disease Control and demonstrations involve waivers of are two topically-focused telephone
Prevention. certain provisions of the foster care surveys: (a) A telephone survey of
[FR Doc. 2016–13982 Filed 6–13–16; 8:45 am] program authorized by title IV–E of the waiver jurisdiction representatives and
BILLING CODE 4163–18–P Social Security Act. Child welfare evaluators who are focused on
agencies in waiver jurisdictions are measuring well-being, and (b) a second
operating demonstrations to implement telephone survey of waiver jurisdiction
DEPARTMENT OF HEALTH AND a variety of programs and interventions representatives and evaluators that is
HUMAN SERICES that serve children and families in an focused on understanding practice and
Administration for Children and effort to improve their safety, systems-level changes within child
Families permanency, and well-being. Each welfare service systems. Also proposed
waiver jurisdiction is required to is a Web-based survey of waiver
Proposed Information Collection conduct a third-party evaluation of its jurisdiction representatives and
Activity: Comment Request demonstration. evaluators that will look more broadly at
The National Study will examine the the implementation of waiver
Proposed Projects extent to which safety, permanency, and demonstrations and corresponding
Title: National Study of Title IV–E well-being outcomes have improved for changes in child welfare policy,
Child Welfare Waiver Demonstrations. children and families; the practice, and financing. Data collected
OMB No.: New Collection. characteristics of waiver jurisdictions through these instruments will be used
Description: The National Study of where improvements in outcomes have by the Children’s Bureau to gain an
the Title IV–E Child Welfare Waiver occurred; expenditure patterns and the understanding of the jurisdictions’
Demonstrations is sponsored by the types of activities for which waiver collective experience with
srobinson on DSK5SPTVN1PROD with NOTICES
Children’s Bureau, Administration for jurisdictions have increased funding; implementing their demonstrations.
Children and Families of the U.S. and the extent to which waiver Respondents: The respondents to the
Department of Health and Human jurisdictions have experienced practice Web-based survey will be a purposive
Services and involves the conduct of a and systems-level changes. The National sample of an estimated 250 waiver
cross-site study of jurisdictions (referred Study uses a mixed-method approach to jurisdiction representatives and
to as waiver jurisdictions) approved to examine 25 waiver jurisdictions evaluators drawn from the 25 waiver
operate demonstrations authorized by (including 23 states, the District of jurisdictions with waiver demonstration
VerDate Sep<11>2014 19:36 Jun 13, 2016 Jkt 238001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\14JNN1.SGM 14JNN1](https://thefederalregister.org/doc/81_FR_38823/page/1.svg)
![38710 Federal Register / Vol. 81, No. 114 / Tuesday, June 14, 2016 / Notices
projects (Arkansas, Arizona, Colorado, National Study. The respondents to the and Systems-Level Change telephone
Hawaii, Illinois, Kentucky, Maine, Well-Being telephone survey will be a survey will be a purposive sample of 60
Maryland, Massachusetts, Michigan, purposive sample of 60 respondents respondents identified from up to 12
Nebraska, Nevada, New York, identified from up to 12 waiver waiver jurisdictions who are
Oklahoma, Oregon, Pennsylvania, Port jurisdictions who are involved with the knowledgeable about practice, policy,
Gamble S’Klallam Tribe, Rhode Island, assessment of child and family well- and organizational changes in their
Tennessee, Texas, Utah, Washington, being in their waiver jurisdictions. The respective waiver jurisdictions. The
Washington DC, West Virginia, Well-Being telephone survey will be Practice and Systems-Level Change
Wisconsin). The Web-based survey will administered once during the National telephone survey will be administered
be administered once during the Study. The respondents to the Practice once during the National Study.
ANNUAL BURDEN ESTIMATES
Number of Average
Number of Total burden
Instrument responses per burden hours
respondents hours
respondent per response
Web-Based Survey .......................................................................................... 250 1 0.33 82.5
Telephone Survey: Well-Being ........................................................................ 60 1 1 60
Telephone Survey: Practice and Systems-Level Change ............................... 60 1 1 60
Estimated Total Annual Burden Hours ..................................................... ........................ ........................ ........................ 202.5
In compliance with the requirements DEPARTMENT OF HEALTH AND 741–8138 (301–443–0572 in the
of section 506(c)(2)(A) of the Paperwork HUMAN SERVICES Washington, DC area). A notice in the
Reduction Act of 1995, the Federal Register about last minute
Administration for Children and Food and Drug Administration modifications that impact a previously
Families is soliciting public comment [Docket No. FDA–2016–N–0001] announced advisory committee meeting
on the specific aspects of the cannot always be published quickly
information collected described above. Arthritis Advisory Committee; Notice enough to provide timely notice.
Copies of the proposed collection of of Meeting Therefore, you should always check the
information can be obtained and Agency’s Web site at http://
AGENCY: Food and Drug Administration, www.fda.gov/AdvisoryCommittees/
comments may be forwarded by writing HHS.
to the Administration for Children and default.htm and scroll down to the
ACTION: Notice. appropriate advisory committee meeting
Families, Office of Planning, Research
link, or call the advisory committee
and Evaluation, 330 C St. SW., SUMMARY: The Food and Drug information line to learn about possible
Washington, DC 20447, Attn: ACF Administration (FDA) announces a modifications before coming to the
Reports Clearance Officer. Email forthcoming public advisory committee meeting.
address: infocollection@acf.hhs.gov. All meeting of the Arthritis Advisory
requests should be identified by the title Committee. The general function of the SUPPLEMENTARY INFORMATION:
of the information collection. committee is to provide advice and Agenda: The committee will discuss
recommendations to the Agency on biologics license application 761024, for
The Department specifically requests ABP 501, a proposed biosimilar to
comments on: (a) Whether the proposed FDA’s regulatory issues. The meeting
will be open to the public. AbbVie Inc.’s HUMIRA (adalimumab),
collection of information is necessary submitted by Amgen, Inc. The proposed
for the proper performance of the DATES: The meeting will be held on July
12, 2016, from 7:30 a.m. to 5 p.m. indications (uses) for this product are:
functions of the agency, including (1) Reducing signs and symptoms,
whether the information shall have ADDRESSES: FDA White Oak Campus,
inducing major clinical response,
practical utility; (b) the accuracy of the 10903 New Hampshire Ave., Bldg. 31 inhibiting the progression of structural
agency’s estimate of the burden of the Conference Center, the Great Room (Rm. damage, and improving physical
proposed collection of information (c) 1503), Silver Spring, MD 20993–0002. function in adult patients with
the quality, utility and clarity of the Answers to commonly asked questions moderately to severely active
including information regarding special rheumatoid arthritis (alone or in
information to be collected, and (d)
accommodations due to a disability, combination with methotrexate or other
ways to minimize the burden of the
visitor parking, and transportation may non-biologic disease-modifying anti-
collection of information on
be accessed at: http://www.fda.gov/ rheumatic drugs (DMARDs)); (2)
respondents, including through the use AdvisoryCommittees/
of automated collection techniques or reducing signs and symptoms of
AboutAdvisoryCommittees/ moderately to severely active
other forms of information technology. ucm408555.htm.
Consideration will be given to polyarticular juvenile idiopathic
comments and suggestions submitted FOR FURTHER INFORMATION CONTACT: arthritis in patients 4 years of age and
Moon Hee V. Choi, Center for Drug older (alone or in combination with
srobinson on DSK5SPTVN1PROD with NOTICES
within 60 days of this publication.
Evaluation and Research, Food and methotrexate); (3) reducing signs and
Robert Sargis, Drug Administration, 10903 New symptoms, inhibiting the progression of
Reports Clearance Officer. Hampshire Ave., Bldg. 31, Rm. 2417, structural damage, and improving
[FR Doc. 2016–13999 Filed 6–13–16; 8:45 am] Silver Spring, MD 20993–0002, 301– physical function in adult patients with
BILLING CODE 4184–01–P
796–9001, FAX: 301–847–8533, AAC@ active psoriatic arthritis (alone or in
fda.hhs.gov, or FDA Advisory combination with non-biologic
Committee Information Line, 1–800– DMARDs); (4) reducing signs and
VerDate Sep<11>2014 19:36 Jun 13, 2016 Jkt 238001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\14JNN1.SGM 14JNN1](https://thefederalregister.org/doc/81_FR_38823/page/2.svg)
Document Created: 2016-06-14 02:58:27
Document Modified: 2016-06-14 02:58:27
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 81 FR 38709 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR